These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 13827321)

  • 1. [Could methyl-2-N-propyl-2-propandiolo-1,3-dicarbamate (meprobamate, miltown, perequil) be ultimately used in chronic lead poisoning?].
    GENTILE G
    Folia Med (Napoli); 1959 Jul; 42():819-24. PubMed ID: 13827321
    [No Abstract]   [Full Text] [Related]  

  • 2. Toxic reaction to 2-methyl-2-n-propyl-1, 3, propanediol dicarbamate (miltown and equanil).
    HOLOUBEK JE; THOMAS OC; SEGURA J
    Ann Intern Med; 1957 May; 46(5):1002-4. PubMed ID: 13411911
    [No Abstract]   [Full Text] [Related]  

  • 3. A clinical evaluation of miltown (2 methyl-2-N-propyl-1, 3 propanediol dicarbamate).
    WEINSTEIN GJ
    N Y State J Med; 1957 Jun; 57(12):2060. PubMed ID: 13441048
    [No Abstract]   [Full Text] [Related]  

  • 4. Nonthrombocytopenic purpura due to Miltown (2-methyl-2-N-propyl-1,3 propanediol dicarbamate).
    Carmel WJ; Dannenberg T
    N Engl J Med; 1956 Oct; 255(16):770-1. PubMed ID: 13369712
    [No Abstract]   [Full Text] [Related]  

  • 5. Central depressant and anticonvulsant activity of compounds isomeric with 2-methyl-2-n-propyl-1, 3-propanediol dicarbamate (miltown).
    BERGER FM; HENDLEY CD; LUDWIG BJ; LYNES TE
    J Pharmacol Exp Ther; 1956 Mar; 116(3):337-42. PubMed ID: 13307395
    [No Abstract]   [Full Text] [Related]  

  • 6. The pharmacological properties of 2-methyl-2-n-propyl-1,3-propanediol dicarbamate (miltown), a new interneuronal blocking agent.
    BERGER FM
    J Pharmacol Exp Ther; 1954 Dec; 112(4):413-23. PubMed ID: 13222235
    [No Abstract]   [Full Text] [Related]  

  • 7. Study of effect of miltown (2-methyl-2-n-propyl-1,3-propanediol dicarbamate) on psychiatric states.
    BORRUS JC
    J Am Med Assoc; 1955 Apr; 157(18):1596-8. PubMed ID: 14367013
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical study of a new tranquilizing drug; use of miltown (2-methyl-2-n-propyl-1,3-propanediol dicarbamate).
    SELLING LS
    J Am Med Assoc; 1955 Apr; 157(18):1594-6. PubMed ID: 14367012
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of 2-methyl, 2-n-propyl-1,3-propanediol dicarbamate (Miltown) on central nervous system.
    HENDLEY CD; LYNES TE; BERGER FM
    Proc Soc Exp Biol Med; 1954 Dec; 87(3):608-10. PubMed ID: 13237321
    [No Abstract]   [Full Text] [Related]  

  • 10. Aplastic anemia after meprobamate (2-methyl-2-N-propyl-1,3-propanediol dicarbamate) therapy.
    MEYER LM; HEEVE WL; BERTSCHER RW
    N Engl J Med; 1957 Jun; 256(26):1232-3. PubMed ID: 13452030
    [No Abstract]   [Full Text] [Related]  

  • 11. [2-Methyl-2-n-propyl-1, 3-propandiol-dicarbamate (meprobamate); experimental results, clinical experiences and own studies on the determination of excretion products].
    RIEBELING C
    Arzneimittelforschung; 1957 Mar; 7(3):181-5. PubMed ID: 13425940
    [No Abstract]   [Full Text] [Related]  

  • 12. [Methyl-propyl-propanediol dicarbamate (meprobamate) in dermatology].
    KAMINSKY A; KAPLAN A; SEVINSKY B
    Minerva Med; 1956 Nov; 47(88):1478-80. PubMed ID: 13387292
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of administration of 2-methyl-2-n-propyl-1, 3-propanediol dicarbamate (meprobamate) in mental disorders].
    IMBERCIADORI S; MANGANARO D
    Minerva Med; 1956 Dec; 47(102):2181-4. PubMed ID: 13399942
    [No Abstract]   [Full Text] [Related]  

  • 14. Psychiatric use of a new tranquilizer: 2-methyl-2-N-propyl-1,3-propanediol dicarbamate (meprobamate).
    MACCAGNANI G
    Rass Neuropsichiatr; 1957; 11(3-4):145-71. PubMed ID: 13506106
    [No Abstract]   [Full Text] [Related]  

  • 15. [A new therapeutic agent against anxiety states; meprobamate (2-methyl-2-N-propyl-1, 3-propandiol dicarbamate)].
    SPOTA BB
    Sem Med; 1957 Feb; 110(7):237-8. PubMed ID: 13454968
    [No Abstract]   [Full Text] [Related]  

  • 16. [Meprobamate (2-methyl-2-n propyl-1,3 proprandiol dicarbamate) in glaucoma & preoperative care in eye surgery].
    LEYDHECKER W
    Klin Monbl Augenheilkd Augenarztl Fortbild; 1958; 132(2):224-33. PubMed ID: 13550760
    [No Abstract]   [Full Text] [Related]  

  • 17. [Early clinical experiments with 2-methyl-2-propyl-1,3-propandiol dicarbamate; new substance with sedative action].
    BALDUINI M
    Farmaco Prat; 1956 Oct; 11(10):565-70. PubMed ID: 13414830
    [No Abstract]   [Full Text] [Related]  

  • 18. [Laboratory study of toxic substance elimination through hemodialysis].
    Boiteau HL; Liot P
    Ann Biol Clin (Paris); 1969; 27(10):687-701. PubMed ID: 4984934
    [No Abstract]   [Full Text] [Related]  

  • 19. Gas chromatographic determination of meprobamate, 2-methyl-2-propyl-1,3-propanediol dicarbamate, in plasma and urine.
    Douglas JF; Kelley TF; Smith NB; Stockage JA
    Anal Chem; 1967 Jul; 39(8):956-8. PubMed ID: 6042638
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.